Resources for your clinical practice

Journal Articles

In this section, you will find guidelines and links to
publications about Alzheimer’s disease.

Diagnosis

Clinical Diagnosis of Alzheimer's Disease: Recommendations of the International Working Group.19 Dubois B et al. (2021)

VIEW ABSTRACT
Care & Interventions

Be He@lthy, Be Mobile: A Handbook on How to Implement mDementia.6 World Health Organization and International Telecommunication Union (2021)

VIEW ARTICLE
Diagnosis

Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021.16
Porsteinsson AP et al. (2021)

VIEW ARTICLE
AD Progression

Estimating Progression Rates Across the Spectrum of Alzheimer's Disease for Amyloid-Positive Individuals Using National Alzheimer's Coordinating Center Data.18 Potashman M et al. (2021)

VIEW ARTICLE
Care & Interventions

Dementia Risk Communication. A User Manual for Brain Health Services-part 3 of 6.17
Visser LNC et al. (2021)

VIEW ARTICLE
Care & Interventions

Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management.7 Galvin JE et al. (2021)

VIEW ARTICLE
Prevention & Brain Health

Risk Reduction of Cognitive Decline and Dementia. WHO - Guidelines.4 World Health Organization (2019)

VIEW ARTICLE
Diagnosis

Toward a Sequential Strategy for Diagnosing Neurocognitive Disorders: A Consensus from the "Act On Dementia" European Joint Action.2 Krolak-Salmon P et al. (2019)

VIEW ARTICLE
Diagnosis

Using Informant and Performance Screening
Methods to Detect Mild Cognitive Impairment and Dementia.3 Galvin JE (2018)

VIEW ARTICLE
Diagnosis

Harmonized Diagnostic Criteria for Alzheimer’s Disease: Recommendations.1 Morris JC et al. (2014)

VIEW ARTICLE
Care & Interventions

EFNS guidelines for the Diagnosis and Management of Alzheimer’s Disease.5 Hort J et al. (2010)

VIEW ARTICLE
VIEW LESS

Medical Educational Programs

ADvance: Alzheimer's Medical Education provided by Biogen

ADvance is a medical education program for healthcare professionals involved in the diagnosis and care of patients with Alzheimer’s disease. It is self-paced, interactive and includes case studies shared by practitioners.

GET STARTED


Patient Engagement and Communication

 

In this section, you will find practical resources to support the journey of patients
affected by AD as well as their care partners. You may want to make these materials
available at your practice.

 

 

Other valuable resources to engage and support patients
living with AD and their care partners are available through
international patient association sites such as:

Alzheimer Europe8

Alzheimer’s Disease International9

Alzheimers.Gov10

Alzheimer’s Association11


Research Initiatives for AD and
Brain Health

 

This section is about ongoing research initiatives for AD. To keep yourself
updated, please visit the websites of the organisations carrying out the research.

 

World Health Organization (WHO) on Healthy Ageing and Dementia12,13

National Institute on Aging14

IMI – Innovative Medicines Initiative – Europe’s Partnership for Health: AD Project Factsheets:15

NEURONET

Efficiently networking European neurodegeneration research

MOPEAD

Models of Patient Engagement for Alzheimer’s Disease

RADAR-AD

Remote Assessment of Disease and Relapse - Alzheimer's Disease

ROADMAP

Real world Outcomes across the AD spectrum for better care: Multi-modal data Access Platform

EPAD

European Prevention of Alzheimer's Dementia consortium

BD4BO

Big Data for Better Outcomes.

References

1.Morris JC, Blennow K, Froelich L, et al. Harmonized diagnostic criteria for Alzheimer’s disease: recommendations. J Intern Med. 2014;275(3):204-213.

2.Krolak-Salmon P, Maillet A, Vanacore N, et al. Toward a Sequential Strategy for Diagnosing Neurocognitive Disorders: A Consensus from the "Act On Dementia" European Joint Action. J Alzheimers Dis. 2019;72(2):363-372.

3.Galvin JE. Using Informant and Performance Screening Methods to Detect Mild Cognitive Impairment and Dementia. Curr Geriatr Rep. 2018;7(1):19-25.

4.Risk reduction of cognitive decline and dementia. WHO Guidelines. Available at: pubmed.ncbi.nlm.nih.gov/31219687. Accessed January, 2022.

5.Hort J, O'Brien JT, Gainotti G, et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol. 2010;17(10):1236-1248.

6.Be He@lthy, Be Mobile: a handbook on how to implement mDementia. Geneva: World Health Organization and International Telecommunication Union, 2021. Available at: https://apps.who.int/iris/bitstream/handle/10665/339846/9789240019966-eng.pdf.

7.Galvin JE, Aisen P, Langbaum JB, et al. Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management. Front Neurol. 2021;11:592302.

8.Alzheimer Europe. www.alzheimer-europe.org. Accessed January, 2022.

9.Alzheimer’s Disease International. www.alzint.org. Accessed January, 2022.

10.Alzheimers.gov. www.alzheimers.gov. Accessed January, 2022.

11.Alzheimer’s Association. www.alz.org. Accessed January, 2022.

12.World Health Organization. Regional Office for Europe. Healthy ageing. www.euro.who.int/en/health-topics/Life-stages/healthy-ageing. Accessed January, 2022.

13.World Health Organization. Dementia. www.who.int/health-topics/dementia#tab=tab_1. Accessed January, 2022.

14.National Institute on Aging. www.nia.nih.gov/health/alzheimers. Accessed January, 2022.

15.Innovative Medicines Initiative. Project Factsheets. www.imi.europa.eu/projects-results/project-factsheets. Accessed January, 2022.

16.Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I. Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021. J Prev Alzheimers Dis. 2021.

17.Visser LNC, Minguillon C, Sánchez-Benavides G, et al. Dementia risk communication. A user manual for Brain Health Services-part 3 of 6. Alzheimers Res Ther. 2021;13(1):170.

18.Potashman M, Buessing M, Levitchi Benea M, et al. Estimating Progression Rates Across the Spectrum of Alzheimer's Disease for Amyloid-Positive Individuals Using National Alzheimer's Coordinating Center Data. Neurol Ther. 2021;10(2):941-953.

19.Dubois B, Villain N, Frisoni GB, et al. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. Lancet Neurol. 2021;20(6):484-496.